סוניטיניב פאדאגיס 25 מ"ג - Sunitinib padagis 25 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×¡×× ×××× ×× ×¤××××××¡ 12.5 ×"× - Sunitinib padagis 12.5 mg ×¡×× ×××× ×× ×¤××××××¡ 50 ×"× - Sunitinib padagis 50 mg ×¡×× ×××× ×× ××¡.×§××. 12.5 ×"× - Sunitinib s.k 12.5 mg ×¡×× ×××× ×× ××¡.×§××. 25 ×"× - Sunitinib s.k 25 mg ×¡×× ×××× ×× ××¡.×§××. 37.5 ×"× - Sunitinib s.k 37.5 mg ×¡×× ×××× ×× ××¡.×§××. 50 ×"× - Sunitinib s.k 50 mg ×¡×× ×××× ×× ×¡× ××× 12.5 ×"× - Sunitinib sandoz 12.5 mg ×¡×× ×××× ×× ×¡× ××× 25 ×"× - Sunitinib sandoz 25 mg ×¡×× ×××× ×× ×¡× ××× 50 ×"× - Sunitinib sandoz 50 mg ×¡×× ×××× ×× ×ª×¨× 12.5 ×"× - Sunitinib taro 12.5 mg â¦ ×ª××¦×××ª × ××¡×¤××ª
×§×××¦× ×¤×¨××§××××××ª (ATC4)	L01EX Other protein kinase inhibitors
××¨××× ×¤×¢×× (ATC5)	Â Sunitinib AS HYDROCHLORIDE 25 MG âL01EX01
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	×§×¤×¡××× ×§×©×××, CAPSULE, HARD ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Sunitinib Padagis is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.Sunitinib Padagis is indicated for the treatment of advanced renal cell carcinoma. Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.12.2024

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¡×× ×××× ×× ×¤××××××¡ 25 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	BLUEPHARMA INDUSTRIA FARMACEUTICA S.A., PORTUGAL
×©× ××¢× ××¨××©××	PADAGIS ISRAEL AGENCIES LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 4/2022. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	12/1/2025

השינוי האחרון נעשה בֹ־19 ביוני 2025 ב־01:32